Drugs / 99Tc methylene diphosphonate
last change Jul 2021 re-read 3 minutes ago

99Tc methylene diphosphonate

Developed for
psoriatic arthritis
Investigated by
Chengdu Yunke Pharmaceutical Co., Ltd. · Peking Union Medical College Hospital

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05000086 Jun 2019 → Jul 2021 psoriatic arthritis Peking Union Medical College Hospital Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 99Tc methylene diphosphonate ClinicalTrials.gov intervention name — accepted as the source's own label NCT05000086 ↗
Route Intravenous “was injected intravenously” NCT05000086 ↗